Syneron Candela Signs Agreement with American Medical Systems to Supply Holmium Laser for Urology

Date Announced: 08 Dec 2014

FDA Clearance for NS3000, a 30 Watt Holmium Laser for the Urology Market.

ROSEVILLE, Calif., Dec. 8, 2014 /PRNewswire/ -- Syneron Medical Ltd. (ELOS), a leading global aesthetic device company, announced today the signing of a multi-year agreement with American Medical Systems (AMS) to supply holmium lasers. AMS, an Endo International plc subsidiary, is a leading global provider of medical technologies for pelvic health conditions. This agreement furthers the partnership between AMS and New Star, a recently acquired subsidiary of Syneron, and its CoolTouch line of products, in supplying holmium lasers for the treatment of kidney stones. New Star helped pioneer the 2100nm Holmium wavelength technology in the early 1990s which is now the standard of care for the treatment of kidney stones and soft-tissue ablation by urologists.

The NS3000, marketed under the name StoneLight™ 30, is a surgical laser device that uses the Holmium wavelength to shatter kidney stones in a minimally invasive manner via a laproscopic or endoscopic procedure. With the new US Food and Drug Administration (FDA) clearance of the NS3000, this 30W laser is positioned as a powerful, robust, yet compact device with the ability to treat larger kidney stones and the precise control of stone breaking, dusting and retropulsion control that physicians want.

"Syneron's CoolTouch brand specializes in medical lasers in a variety of wavelengths for various minimally invasive surgical procedures," said Ilan Ben David, CEO of CoolTouch. "We value our relationship with AMS and look forward to continued product development in the field of medical lasers to enhance our product offerings."

"The opportunity to provide laser devices to the urology market enables Syneron to expand our core competency to the surgical market," stated Amit Meridor, CEO of Syneron Candela. "We are confident that the FDA clearance of the NS3000 holmium laser will enhance our ability to provide excellent laser solutions for the urology market."

Source: Syneron Medical

Contact

E-mail: via web site

Web Site: www.syneron-candela.com